arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

Synergy CHC Corp.

SNYR
$0.17 0.00 (+0.24%) at close
Materials ·Medicinal Chemicals & Botanical Products ·USMedicinal Chemicals & Botanical Products
43 Visible periods
32 Metrics
Peer-ranked Benchmarks
Price Chart
54
Health
Fair
Neutral
auto_awesome

Analytical Summary

Synergy CHC Corp. demonstrates solid fundamentals with strength in Return on Common Equity (%). However, watch Operating Margin (%) and Profit Margin (%) which show concerning trends. Consider comparing against peers in the Materials sector before making investment decisions.

Market Cap $1.9M
Dividend Yield
Revenue Growth -32.8%
Op. Margin -10.3%
ROIC 145.7%
FCF / Share $-0.18
Trailing P/E
Price / Book
FCF Yield
Debt / Equity -0.98
info Valuation on last close. End-of-day price, Aug 6, 2026.

43-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$5.49M
↓ -32.8%
Net Income Profit after all expenses
$-2.57M
↑ +82.7%
Operating Margin Operating profit as % of sales
-10.3%
↑ +95.3% 8th
FCF / Share Free cash flow per share
$-0.18
↓ -88.2%
Long-Term Debt Long-term obligations
$25.02M
— -0.2%
trending_up

Bullish Indicators

  • Debt to EquityDebt to Equity is in the top quartile (lower is better)
  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability
9
Returns
97
Financial Health
69
Cash Quality
30

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 10 years · 43 quarters